Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru

A Case Series

Miguel Cabada, Martha Lopez, Maria Cruz, Jennifer R. Delgado, Virginia Hill, A. Clinton White

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Triclabendazole is reported to be highly effective in treatment of human fascioliasis. We present 7 of 19 selected cases of human fascioliasis referred to our center in the Cusco region of Peru that failed to respond to triclabendazole. These were mostly symptomatic adults of both sexes that continued passing Fasciola eggs in the stool despite multiple treatments with 2 doses of triclabendazole at 10 mg/kg per dose. We documented the presence of eggs by rapid sedimentation and Kato Katz tests after each treatment course. We found that repeated triclabendazole courses were not effective against fascioliasis in this group of people. These findings suggest that resistance to triclabendazole may be an emerging problem in the Andes.

Original languageEnglish (US)
Article numbere0004361
JournalPLoS Neglected Tropical Diseases
Volume10
Issue number1
DOIs
StatePublished - Jan 25 2016

Fingerprint

triclabendazole
Fascioliasis
Peru
Treatment Failure
Eggs
Fasciola
Therapeutics

ASJC Scopus subject areas

  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru : A Case Series. / Cabada, Miguel; Lopez, Martha; Cruz, Maria; Delgado, Jennifer R.; Hill, Virginia; White, A. Clinton.

In: PLoS Neglected Tropical Diseases, Vol. 10, No. 1, e0004361, 25.01.2016.

Research output: Contribution to journalArticle

@article{9c84b0a8e6164bcb93339bc7c111e731,
title = "Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series",
abstract = "Triclabendazole is reported to be highly effective in treatment of human fascioliasis. We present 7 of 19 selected cases of human fascioliasis referred to our center in the Cusco region of Peru that failed to respond to triclabendazole. These were mostly symptomatic adults of both sexes that continued passing Fasciola eggs in the stool despite multiple treatments with 2 doses of triclabendazole at 10 mg/kg per dose. We documented the presence of eggs by rapid sedimentation and Kato Katz tests after each treatment course. We found that repeated triclabendazole courses were not effective against fascioliasis in this group of people. These findings suggest that resistance to triclabendazole may be an emerging problem in the Andes.",
author = "Miguel Cabada and Martha Lopez and Maria Cruz and Delgado, {Jennifer R.} and Virginia Hill and White, {A. Clinton}",
year = "2016",
month = "1",
day = "25",
doi = "10.1371/journal.pntd.0004361",
language = "English (US)",
volume = "10",
journal = "PLoS Neglected Tropical Diseases",
issn = "1935-2727",
publisher = "Public Library of Science",
number = "1",

}

TY - JOUR

T1 - Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru

T2 - A Case Series

AU - Cabada, Miguel

AU - Lopez, Martha

AU - Cruz, Maria

AU - Delgado, Jennifer R.

AU - Hill, Virginia

AU - White, A. Clinton

PY - 2016/1/25

Y1 - 2016/1/25

N2 - Triclabendazole is reported to be highly effective in treatment of human fascioliasis. We present 7 of 19 selected cases of human fascioliasis referred to our center in the Cusco region of Peru that failed to respond to triclabendazole. These were mostly symptomatic adults of both sexes that continued passing Fasciola eggs in the stool despite multiple treatments with 2 doses of triclabendazole at 10 mg/kg per dose. We documented the presence of eggs by rapid sedimentation and Kato Katz tests after each treatment course. We found that repeated triclabendazole courses were not effective against fascioliasis in this group of people. These findings suggest that resistance to triclabendazole may be an emerging problem in the Andes.

AB - Triclabendazole is reported to be highly effective in treatment of human fascioliasis. We present 7 of 19 selected cases of human fascioliasis referred to our center in the Cusco region of Peru that failed to respond to triclabendazole. These were mostly symptomatic adults of both sexes that continued passing Fasciola eggs in the stool despite multiple treatments with 2 doses of triclabendazole at 10 mg/kg per dose. We documented the presence of eggs by rapid sedimentation and Kato Katz tests after each treatment course. We found that repeated triclabendazole courses were not effective against fascioliasis in this group of people. These findings suggest that resistance to triclabendazole may be an emerging problem in the Andes.

UR - http://www.scopus.com/inward/record.url?scp=84969427415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969427415&partnerID=8YFLogxK

U2 - 10.1371/journal.pntd.0004361

DO - 10.1371/journal.pntd.0004361

M3 - Article

VL - 10

JO - PLoS Neglected Tropical Diseases

JF - PLoS Neglected Tropical Diseases

SN - 1935-2727

IS - 1

M1 - e0004361

ER -